Benha University, Egypt
Dr. Aboubakr Elnashar is a Professor of Obstetrics and Gynecology at Benha University, Egypt. He is the President of clinical society of obs and gyn. He is the member of the board of Egyptian Society of Fertility & sterility from 2015 and till now. He is the editor of the Egyptian Fertility sterility Journal and the Benha Medical Journal. He is the Associate Editor of Middle East fertility Society Journal. He was the assistant secretary general of Egyptian society of fertility & Sterility (2002- 2006). Dr. Elnashar had many publications both national and international. He is managing and directing of many training courses in cytology, colposcopy, ultrasonography, foetal monitor, reproductive endocrinology and ART. Qualification includes, M.B.CH.B. (Very good with honor, 1978, Zagazig University) Post graduate qualifications 1. Master in Ob/Gyn (Very good, 1982), Zagazig University 2. Diploma in cervical pathology (1986, Barcelona, Spain) 3. Medical Doctora in Ob/Gyn (1989, Zagazig University) Post graduate appointments Registrar, assistant lecturer, Lecturer, Assistant professor Ob/Gyn in Benha Faculty of Medicine from January 1996. Appointments 1. Professor of Ob/Gyn, Benha Faculty of Medicine, Egypt, from March 2001 till now 2. Chief of early detection of cancer unit, Benha University Hospital, Egypt. 3. Consultant of IVF &ICSI in Delta Fertility Center & Benha Fertility Center, Egypt.
PTL is the most common cause of perinatal morbidity and mortality in the world. PTL early in pregnancy is more likely due to infection. Antibiotic prophylaxis during the second or third trimester of pregnancy is effective in reducing risk of PTL in pregnant women with bacterial vaginosis (BV) in the current pregnancy, pre-labour rupture of membranes, postpartum endometritis. Limited data showed that routine use of antibiotics during pregnancy might prevent infectious morbidity for the mother, but could not reduce neonatal morbidity and mortality. Prophylactic antibiotics is not indicated for previous PTL of unknown aetiology but for abnormal genital tract microflora detected in current pregnancy. BV is more likely to respond to oral clindamycin than metronidazole.